Who are we?
We are a young, innovative, research-led company that designs, develops and creates novel solutions to tissue culture limitations to meet your research needs.
What is our Company Mission?
The Company’s mission is to provide bespoke products that allow our customers to fully exploit the in-vitro culture of cells in applications related to regenerative medicine, diseases such as cancer and diabetes, in-vitro drug screening and for incorporation into bioinks.
What is different about our products?
- Our PhenoDrive products promote the formation of 3D cell spheroids from 2D culture systems without need for gels.
- PhenoDrives are animal component free and are provided as lyophilised powders that are easily reconstituted and incorporated into your existing protocols.
- PhenoDrives are a range of fully synthetic, biomimetic materials to provide simple, single step solutions to promote your cell culture models and preserve phenotype through mimicry of the extra cellular matrix.
- Nanosperse allows the simple dispersal of nanoparticles for individual testing and study
Where are we based?
We are based in the city of Brighton and Hove, East Sussex, England
Funded By
Horizon 2020 research and innovation programme.
The EU project MEFISTO is taking on the challenge of developing innovative ways of using bioactive functionalised materials to prevent the onset of osteoarthritis following meniscus loss. Tissue Click Ltd is providing the bioactive mimics to manipulate the cells surrounding the implants to modify their behaviour. https://www.mefisto-project.eu
Funded By
Innovate UK, the UK’s innovation agency.
Along with our European partner the University of Salerno, we have developed a kit for the sensitive, rapid and inexpensive diagnosis of Covid-19 infection. The project was co-funded by Innovate UK, under the competitive funding scheme UKRI Open call for research and innovation ideas to address COVID-19.
Funded By
Horizon 2020 Large-scale research initiative programme
The RESTORE project is a comprehensive 10 year programme to increase the awareness of advanced therapies to the European Commission, European Parliament, scientific community, patient advocates and the public.
Funded By
Horizon 2020 European Funding for Research & Innovation
The CENSUS project worked towards providing a technical solution for neurodegenerative disorders. The project produced CNS cell models from a consistent, renewable source, in the form of induced pluripotent stem cells (iPSC).
Our Key Team
Discover the TissueClick staff credentials
Dr Iain Allan is the Chief Scientific Officer of Tissue Click Ltd and has over 20 year’s research experience in the field. Originally trained in microbiology, he has developed a special interest and expertise in developing novel biomaterials for tissue regeneration. He also has experience in assessing the in vitro performance of these using a range of cell culture and image analyses techniques.
Prior to joining Tissue Click, Iain’s academic research focused on developing and evaluating novel tissue regeneration matrices for the repair of dermal wounds, and antimicrobial materials intended for healthcare applications.
Dr Allan has a PhD in antimicrobial biomaterials from University College London, and an honours degree in microbiology from the University of Glasgow. He has been awarded £4.39 million in research funding and has published extensively.
Contact i.allan@tissueclick.com
Sophie Nezha is the Tissue Click Research Technician. She has considerable experience in synthesising the range of Tissue Click products in our company laboratory.
Sophie has recently achieved a Master of Research degree in Regenerative Medicine and Devices at the University of Brighton.
Sophie worked extensively with the PhenoDrive products during both her undergraduate and postgraduate degrees, acquiring considerable expertise on the synthesis and application of these in cell culture research.
Contact s.nezha@tissueclick.com
Want to discuss your project further with the TissueClick team? Contact us
